The mutual activation of PD-1 and PD-L1 will change the metabolism of T cells, so as to participate in the suppression of immune response and maintain peripheral tolerance, and its overexpression can make tumor cells evade immune surveillance. The gene discussed is CD274; the disease is neoplasm.